VeriSIM Life

San Francisco, United States Founded: 2017 • Age: 9 yrs
AI-based biosimulation models are used for drug development predictions.

About VeriSIM Life

VeriSIM Life is a company based in San Francisco (United States) founded in 2017 by Jyotika Varshney.. VeriSIM Life has raised $21.4 million across 6 funding rounds from investors including NIH, Debiopharm and HHS. The company has 13 employees as of December 31, 2021. VeriSIM Life has completed 1 acquisition, including Molomics. VeriSIM Life offers products and services including BIOiSIM and AtlasGEN. VeriSIM Life operates in a competitive market with competitors including Owkin, Formation Bio, AbSci, BigHat and Predictive Oncology, among others.

  • Headquarter San Francisco, United States
  • Employees 13 as on 31 Dec, 2021
  • Founders Jyotika Varshney
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Verisim Life, Inc
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $21.4 M (USD)

    in 6 rounds

  • Latest Funding Round
  • Investors
    NIH

    & 13 more

  • Employee Count
    13

    as on Dec 31, 2021

  • Investments & Acquisitions
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of VeriSIM Life

VeriSIM Life offers a comprehensive portfolio of products and services, including BIOiSIM and AtlasGEN. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Platform for predicting drug outcomes and optimizing clinical trials

Generates and evaluates new drug molecules for safety and efficacy

People of VeriSIM Life
Headcount 10-50
Employee Profiles 11
Board Members and Advisors 4
Employee Profiles
People
Gordon Murtaugh
VP, Corporate Development
People
Roshan Bhave
Senior AI & ML Solutions Architect
People
Yogesh Bundey
Senior Machine Learning Engineer
People
Brittni Wareham
Executive Assistant

Unlock access to complete

Board Members and Advisors
people
Harry Glaser
Advisor
people
Jeff Barrett
Advisor
people
Rick Sax
Strategic Advisor
people
Alexander Harmsen
Advisor

Unlock access to complete

Funding Insights of VeriSIM Life

VeriSIM Life has successfully raised a total of $21.4M across 6 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 6
  • Last Round
  • First Round

    (26 Feb 2018)

  • Investors Count 14
Date Amount Transaction Name Valuation Lead Investors Investors
Apr, 2022 Amount Grant - VeriSIM Life Valuation

investors

NIH
Apr, 2022 Amount Grant - VeriSIM Life Valuation

investors

HHS
Jan, 2022 Amount Series A - VeriSIM Life Valuation Morpheus Ventures
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in VeriSIM Life

VeriSIM Life has secured backing from 14 investors, including institutional and venture fund investors. Prominent investors backing the company include NIH, Debiopharm and HHS. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Early-stage technology investments are managed by Morpheus Ventures.
Founded Year Domain Location
Seed and early-stage US venture capital investments are managed.
Founded Year Domain Location
Investment in technology startups focusing on compute, AI, and related innovations.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by VeriSIM Life

VeriSIM Life has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Molomics. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Acquisitions
Company Name Description Domain Location Founded Year Amount
Mobile game-based drug design platform
2015
Company Name Description Domain Location Founded Year Amount
OVO is recognized as a smart digital payment application.
2017
Bionic investment advisor platform
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014

Financial Statements - VeriSIM Life

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Verisim Life Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of VeriSIM Life

VeriSIM Life operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Owkin, Formation Bio, AbSci, BigHat and Predictive Oncology, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
An agentic AI platform is developed for biomedical research insights.
domain founded_year HQ Location
AI-powered drug discovery platform for various diseases
domain founded_year HQ Location
AI-based technology is used for recombinant protein production in therapeutics.
domain founded_year HQ Location
Antibody therapies are developed through machine learning and synthetic biology.
domain founded_year HQ Location
AI-based platform for cancer diagnostics and precision medicine is utilized.
domain founded_year HQ Location
AI platform used for extracting antibody data from scientific papers.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Frequently Asked Questions about VeriSIM Life

When was VeriSIM Life founded?

VeriSIM Life was founded in 2017 and raised its 1st funding round 1 year after it was founded.

Where is VeriSIM Life located?

VeriSIM Life is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.

Who is the current CEO of VeriSIM Life?

Jyotika Varshney is the current CEO of VeriSIM Life. They have also founded this company.

Is VeriSIM Life a funded company?

VeriSIM Life is a funded company, having raised a total of $21.4M across 6 funding rounds to date. The company's 1st funding round was a Series A of $15M, raised on Feb 26, 2018.

How many employees does VeriSIM Life have?

As of Dec 31, 2021, the latest employee count at VeriSIM Life is 13.

What does VeriSIM Life do?

VeriSIM Life was founded in 2017 in San Francisco, United States, within the biotech software sector. AI-driven biosimulation models are provided to pharmaceutical companies for predicting drug interactions in animal models. Multiple drugs can be evaluated for in vivo properties through the software, which supports cost reduction and alternatives to physical animal testing in the drug development pipeline.

Who are the top competitors of VeriSIM Life?

VeriSIM Life's top competitors include Owkin, Formation Bio and XtalPi.

What products or services does VeriSIM Life offer?

VeriSIM Life offers BIOiSIM and AtlasGEN.

How many acquisitions has VeriSIM Life made?

VeriSIM Life has made 1 acquisition, including Molomics.

Who are VeriSIM Life's investors?

VeriSIM Life has 14 investors. Key investors include NIH, Debiopharm, HHS, Colorcon, and Morpheus Ventures.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available